Associated Papers
Genotype-Phenotype Features of Germline Variants of the TMEM127 Pheochromocytoma Susceptibility Gene: A 10-Year Update.
Armaiz-Pena G et al.
The Journal of Clinical Endocrinology and Metabolism, 2021
Functional Characterization of TMEM127 Variants Reveals Novel Insights into Its Membrane Topology and Trafficking.
Flores SK et al.
The Journal of Clinical Endocrinology and Metabolism, 2020
The TMEM127 human tumor suppressor is a component of the mTORC1 lysosomal nutrient-sensing complex.
Deng Y et al.
Human Molecular Genetics, 2018
Molecular and phenotypic evaluation of a novel germline TMEM127 mutation with an uncommon clinical presentation.
Deng Y et al.
Endocrine-related Cancer, 2017
Clinical Characterization of the Pheochromocytoma and Paraganglioma Susceptibility Genes SDHA, TMEM127, MAX, and SDHAF2 for Gene-Informed Prevention.
Bausch B et al.
Jama Oncology, 2017
Select a paper to view details